Billionaire Profile
Alexey Repik
Global Rank
#1700

Image: Unsplash Contributor | Unsplash License | via Unsplash

Alexey Repik

CEO, Pharmaceuticals
RUSSIA
Real-Time Net Worth
$2.424B
Estimated based on Pharmaceuticals stock value as of March 6, 2026
0% (24h)
Age
46
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
RUSSIA

Biography

Alexey Repik is a prominent Russian businessman and public figure, born in Moscow in 1979. He is the founder of R-Pharm, a leading Russian pharmaceutical company and one of the largest state contractors, and is currently ranked #1770 in the world. Repik's wealth source stems from his successful ventures in the Pharmaceuticals industry. He is also the Chairman of the All-Russian public organization 'Business Russia', which unites over 7,000 entrepreneurs. His career in healthcare began in 1995, with his entrepreneurial journey leading to the founding of R-Pharm in 2001. Repik's achievements include developing R-Pharm into a major player in the Russian pharmaceutical market, with international presence and collaborations.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life and Education

Alexey Evgenievich Repik was born in Moscow on August 27, 1979. His father is a physicist, and his mother is a candidate of technical sciences. Repik graduated from the Moscow Gymnasium and later graduated from the Higher School of Economics in 2003 with a degree in Economics and Enterprise Management.

Rise to Success

Repik began his career in healthcare in 1995. He founded R-Pharm in 2001 with an initial capital of $40,000, with half of the capital coming from his mother. R-Pharm has grown into a major pharmaceutical company in Russia, involved in research, development, and production of various pharmaceutical products. In 2017, Mitsui & Co., Ltd. acquired a 10% share of R-Pharm for $200 million. Repik's company has also been involved in state contracts and has expanded internationally, with branches in the US, Japan, and Turkey.

Key Business Strategies

R-Pharm's success is linked to its focus on innovation, research and development, and strategic partnerships. The company has invested heavily in infrastructure, production facilities, and R&D. Repik has also served as the Chairman of Delovaya Rossiya (Business Russia).

Philanthropy

Repik is involved in charitable initiatives. He is donating for the construction of a large shelter for 1,500 dogs per year in Yaroslavl, a city 250 kilometers from Moscow.

Career Milestones

2001

Founded R-Pharm

Established R-Pharm, a pharmaceutical company, with an initial capital of $40,000.

2012

Co-chairman of Business Russia

Became co-chairman for international activities of the All-Russian public organization 'Business Russia'.

2014

President of Delovaya Rossiya

Elected president of the 'Delovaya Rossiya' organization and also became a member of the Supervisory Board of the ANO Agency for Strategic Initiatives.

2019

Chairman of Business Russia

Became chairman of the 'Delovaya Rossiya' organization.

Philanthropy & Social Impact

Animal Welfare

Dog Shelter

$XB

Donating for the construction of a large shelter for 1,500 dogs per year in Yaroslavl, a city 250 kilometers from Moscow.

Business Philosophy & Leadership

Notable Quotes

""I have no plane; I have no yacht; not even an island, that's what is the most pity.""

Controversies & Challenges

2023

Wine Smuggling Allegations

Accusations of manipulating loopholes to import millions of dollars worth of luxury alcohol into Russia despite international sanctions and an EU ban.

2022

Mariupol Construction

Repik is the real owner of R-Stroy, a company that is one of the main developers of occupied Mariupol.